Fibril formation by mutational variants of human lysozyme is associated with a fatal form of hereditary non-neuropathic systemic amyloidosis. Defining the mechanistic details of lysozyme aggregation is of crucial importance for understanding the origin and progression of this disease and related misfolding conditions. In this study, we show that a biotin moiety can be introduced site-specifically at Lys33 of human lysozyme. We demonstrate, using biophysical techniques, that the structure and stability of the native-state of the protein are not detectably altered by this modification, and that the ability to form amyloid fibrils is unchanged. By taking advantage of biotin-avidin interactions, we show that super-resolution fluorescence micros...
Identifying the cause of the cytotoxicity of species populated during amyloid formation is crucial t...
Tissue deposition of soluble proteins as amyloid fibrils underlies a range of fatal diseases. The tw...
The partial unfolding of human lysozyme underlies its conversion from the soluble state into amyloid...
Fibril formation by mutational variants of human lysozyme is associated with a fatal form of heredit...
Fibril formation by mutational variants of human lysozyme is associated with a fatal form of heredit...
Human lysozyme (HuL) is a widely characterised protein whose mutational variants misfold, forming am...
Human lysozyme variants form amyloid fibrils in individuals suffering from a familial non-neuropathi...
We report here the detailed characterisation of a non-naturally occurring variant of human lysozyme,...
Six variants of human lysozyme (single-point mutations I56T, F57I, W64R, D67H and double mutations F...
Formation of large fibers and plaques by amyloid proteins is recognized as the molecular hallmark of...
AbstractAL amyloidosis is characterized by the pathologic deposition as fibrils of monoclonal light ...
Deposition of protein fibers with a characteristic cross-β sheet structure is the molecular marker a...
The aggregation process of wild-type human lysozyme at pH3.0 and 60 degrees C has been analyzed by c...
Six variants of human lysozyme (single-point mutations I56T, F57I, W64R, D67H and double mutations ...
Tissue deposition of soluble proteins as amyloid fibrils underlies a range of fatal diseases. The tw...
Identifying the cause of the cytotoxicity of species populated during amyloid formation is crucial t...
Tissue deposition of soluble proteins as amyloid fibrils underlies a range of fatal diseases. The tw...
The partial unfolding of human lysozyme underlies its conversion from the soluble state into amyloid...
Fibril formation by mutational variants of human lysozyme is associated with a fatal form of heredit...
Fibril formation by mutational variants of human lysozyme is associated with a fatal form of heredit...
Human lysozyme (HuL) is a widely characterised protein whose mutational variants misfold, forming am...
Human lysozyme variants form amyloid fibrils in individuals suffering from a familial non-neuropathi...
We report here the detailed characterisation of a non-naturally occurring variant of human lysozyme,...
Six variants of human lysozyme (single-point mutations I56T, F57I, W64R, D67H and double mutations F...
Formation of large fibers and plaques by amyloid proteins is recognized as the molecular hallmark of...
AbstractAL amyloidosis is characterized by the pathologic deposition as fibrils of monoclonal light ...
Deposition of protein fibers with a characteristic cross-β sheet structure is the molecular marker a...
The aggregation process of wild-type human lysozyme at pH3.0 and 60 degrees C has been analyzed by c...
Six variants of human lysozyme (single-point mutations I56T, F57I, W64R, D67H and double mutations ...
Tissue deposition of soluble proteins as amyloid fibrils underlies a range of fatal diseases. The tw...
Identifying the cause of the cytotoxicity of species populated during amyloid formation is crucial t...
Tissue deposition of soluble proteins as amyloid fibrils underlies a range of fatal diseases. The tw...
The partial unfolding of human lysozyme underlies its conversion from the soluble state into amyloid...